Instil Bio (TIL) Earnings Date & Reports

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer... Show more

Industry: #Precious Metals

Get AI intraday signals

A.I. Advisor

published Earnings

TIL is expected to report earnings to fall 73.02% to -17 cents per share on November 16

Q3'26

Est.

$-0.17

Q2'26

Missed

by $0.21

Q1'26

Beat

by $3.38

Q4'25

Beat

by $0.51

Q3'25

Beat

by $1.38

The last earnings report on August 14 showed earnings per share of -62 cents, missing the estimate of -41 cents. With 6.49K shares outstanding, the current market capitalization sits at 51.41M.

View a ticker or compare two or three

Ask AI

Compare

Penny Stock - Smart AI Trend Trader 60min, (FA)Penny Stock - Smart AI Trend Trader 60min, (FA)

Annualized Return+24%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

TIL

Setup

Daily Signal:

Description

Gain/Loss: